Search results: Found 5

Listing 1 - 5 of 5
Sort by
Rabies Symptoms, Diagnosis, Prophylaxis and Treatment

Authors: ---
ISBN: 9783038426820 9783038426837 Year: Pages: 314 Language: English
Publisher: MDPI - Multidisciplinary Digital Publishing Institute
Subject: Medicine (General)
Added to DOAB on : 2018-02-26 15:43:30
License:

Loading...
Export citation

Choose an application

Abstract

Rabies is an acute, progressive, incurable viral encephalitis and one of the oldest described infectious diseases. All mammals are susceptible to infection, but rabid dogs are responsible for the greatest global burden. Bats and carnivores are the major wildlife reservoirs. More than 60,000 persons, primarily children, succumb each year after the bite from a rabid animal. This compilation describes new information on disease surveillance, diagnosis, prevention and control within Africa, Eurasia and the New World. Public health professionals, veterinarians, physicians, laboratory workers and conservation biologists should appreciate the novel communications provided from internationally renowned authors and the diversity of topics in this special issue on rabies.

Towards Elimination of Dog Mediated Human Rabies

Authors: --- --- ---
Book Series: Frontiers Research Topics ISSN: 16648714 ISBN: 9782889452996 Year: Pages: 148 DOI: 10.3389/978-2-88945-299-6 Language: English
Publisher: Frontiers Media SA
Subject: Medicine (General) --- Public Health --- Animal Sciences
Added to DOAB on : 2018-02-27 16:16:44
License:

Loading...
Export citation

Choose an application

Abstract

Rabies is an ancient zoonotic viral disease that still exerts a high impact on human and animal health. The disease is almost 100% fatal after clinical signs appear, and it kills tens of thousands of people per year worldwide, particularly in Africa and many parts of Asia. Although the disease in humans can be prevented by timely post-exposure prophylaxis, its access and affordability is limited in rabies endemic countries. With 99% of infections in humans caused by rabid domestic dog bites, controlling the infection in this reservoir population has been proven to be most effective to reduce and eliminate human rabies cases. In this context, this Research Topic invited contributions on the control and elimination of dog mediated human rabies. Publications on epidemiological, educational, policy-related and economic aspects of dog and human rabies surveillance, implementation of control in dogs and humans and scientific documentation of success stories were consolidated. We hope that these articles contribute to reaching the ambitious goal, set by key players in global health, of the elimination of dog mediated human rabies by 2030.

One Health and Zoonoses

Authors: ---
ISBN: 9783039212958 / 9783039212965 Year: Pages: 140 DOI: 10.3390/books978-3-03921-296-5 Language: eng
Publisher: MDPI - Multidisciplinary Digital Publishing Institute
Subject: Public Health
Added to DOAB on : 2019-12-09 16:10:12
License:

Loading...
Export citation

Choose an application

Abstract

The One Health concept recognizes that the health of humans, animals, and their ecosystems are interconnected, and that a coordinated, collaborative, multidisciplinary, and cross-sectoral approach is necessary to fully understand and respond to potential or existing risks that originate at the animal–human–ecosystems interfaces. Thus, the One Health concept represents a holistic vision for addressing some of the complex challenges that threaten human and animal health, food safety, and the environments in which diseases flourish. There are many examples showing how the health of humans is related to the health of animals and the environment. Diseases shared between humans and animals are zoonoses. Some zoonoses have been known for many years, whereas others have emerged suddenly and unexpectedly. Over 70% of all new emerging diseases over the past few decades have been zoonoses that have emerged from wildlife, most often from bats, rodents, or birds. Examples of zoonoses are many and varied, ranging from rabies to bovine tuberculosis, and from Japanese encephalitis to SARS. Clearly, a One Health approach is essential for understanding their ecology, and for outbreak response and the development of control strategies. However, the One Health concept and approach is much broader than zoonoses; it extends to including antimicrobial resistance, food safety, and environmental health and, consequently, impacts on global health security, economic wellbeing, and international trade. It is this breadth of One Health that connects the papers in this Special Issue.

Prospects for Schistosomiasis Elimination

Authors: ---
ISBN: 9783039213573 / 9783039213580 Year: Pages: 308 DOI: 10.3390/books978-3-03921-358-0 Language: eng
Publisher: MDPI - Multidisciplinary Digital Publishing Institute
Subject: Medicine (General) --- Internal medicine
Added to DOAB on : 2019-12-09 11:49:15
License:

Loading...
Export citation

Choose an application

Abstract

Current efforts to limit the ravages of schistosomiasis are pushing the world closer to eliminating a chronic infection that has been associated with human life in the tropics since time immemorial. This notwithstanding, the disease remains a scourge for large populations in sub-Saharan Africa, Latin America, and Southeast Asia, and the main part of this book is made up by papers dealing with its current distribution, discussing ways and means to establish and implement improved control approaches. While chemotherapy limits the symptoms caused by schistosomiasis, the number of infected people will not decrease until the parasite's life cycle is interrupted. To that end, some papers focus on the intermediate snail host, which is notoriously difficult to control, while others discuss human hygiene and sanitation. The latter approach not only prevents infection through avoiding people being infected from the snail, but more importantly, also stops people infecting the snail by leaving contagious feces and urine in nature. With morbidity reduced by chemotherapy, the immediate target now is the interruption of transmission to be achieved by new tools, such as the novel chemotherapies, improved diagnostics (for humans, animals, and snails), and vaccines discussed in several of the papers. As made clear in this book, a complex infection requires new tools as well as work on many fronts, above all; however, a clear idea is needed as to how to skillfully combine the tools available and sustain implemented control activities.

Keywords

schistosomiasis --- Schistosoma --- vaccine --- zoonosis --- Asia --- Africa --- domestic animals --- buffalo --- cattle --- sheep --- goats --- Côte d’Ivoire --- coverage rate --- praziquantel --- preventive chemotherapy --- Schistosoma haematobium --- Schistosoma mansoni --- schistosomiasis --- diagnosis --- control and elimination --- DNA --- polymerase chain reaction --- schistosomiasis --- control --- elimination --- Africa --- operational research --- goals --- guidelines --- schistosomiasis --- vector control --- snail resistance --- gene drive --- transgenic snail --- schistosomiasis --- Kato-Katz --- POC-CCA --- young adults --- soil-transmitted helminths --- n/a --- Mayuge --- MDA coverage --- praziquantel --- S. mansoni --- systematic non-compliance --- treatment-opportunities --- Uganda --- climate change --- schistosomiasis --- distribution --- intermediate snail host --- transmission --- modelling --- schistosomiasis --- soil-transmitted-helminthiasis --- mapping --- preventive chemotherapy --- transmission control --- Gabon --- Central Africa --- schistosomiasis --- vaccine --- Sm14 --- FABP --- Schistosoma japonicum --- Oncomelania hupensis --- snail --- 28S ribosomal DNA --- PCR --- loop-mediated isothermal amplification (LAMP) --- pooled samples --- China --- schistosomiasis --- elimination --- praziquantel --- artemether --- combination therapy --- phylogeography --- Bulinus truncatus --- planorbidae --- Africa --- schistosomiasis --- neglected tropical diseases --- WIPO Re:Search --- BIO Ventures for Global Health --- cross-sector collaboration --- capacity-building --- drug discovery --- public-private partnerships --- GIS --- remote-sensing --- satellite --- international space station --- ECOSTRESS --- worldview --- spatio-temporal epidemiology --- climate change --- parasite --- schistosomiasis, leishmaniasis --- n/a --- schistosomiasis --- systems epidemiology --- systems thinking --- complexity --- neglected tropical diseases --- interdisciplinarity --- Schistosomiasis mansoni --- Caribbean --- elimination --- snail control --- Biomphalaria glabrata --- Schistosoma mekongi --- Neotricula aperta --- snail --- Cambodia --- Lao PDR --- elimination --- Asia --- control --- elimination --- epidemiology --- Schistosoma japonicum --- Schistosoma malayensis --- Schistosoma mekongi --- schistosomiasis --- Schistosomiasis --- Philippines --- schistosomiasis elimination --- S. japonicum zoonosis --- bovines --- schistosomiasis elimination --- snail control --- high-sensitivity diagnostics --- chemotherapy --- vaccine development --- health education --- sanitation

Hurdles for Phage Therapy (PT) to Become a Reality

Author:
ISBN: 9783039213917 / 9783039213924 Year: Pages: 484 DOI: 10.3390/books978-3-03921-392-4 Language: eng
Publisher: MDPI - Multidisciplinary Digital Publishing Institute
Subject: Science (General) --- Biology --- Microbiology
Added to DOAB on : 2019-12-09 11:49:15
License:

Loading...
Export citation

Choose an application

Abstract

Alternative treatment modes for antibiotic-resistant bacterial pathogens have become a public health priority. Bacteriophages are bacterial viruses that infect and lyse bacterial cells. Since bacteriophages are frequently bacterial host species-specific and can often also infect antibiotic-resistant bacterial cells, they could represent ideal antimicrobials for fighting the antibiotic resistance crisis. The medical use of bacteriophages has become known as phage therapy. It is widely used in Russia, where phage cocktails are sold in pharmacies as an over-the-counter drug. However, no phage product has been registered for medical purposes outside of the former Soviet Union. The current Special Issue of Viruses contains a collection of papers from opinion leaders in the field who explore hurdles to the introduction of phage therapy in western countries. The articles cover diverse topics ranging from patent to regulatory issues, the targeting of suitable bacterial infections, and the selection and characterization of safe and efficient phage cocktails. Phage resistance is discussed, and gaps in our knowledge of phage–bacterium interactions in the mammalian body are revealed, while other articles explore the use of phages in food production and processing.

Keywords

Staphylococcus aureus --- bacteriophage --- phage therapy --- vB_SauM-fRuSau02 --- Twortlikevirus --- antibiotic --- antimicrobial resistance --- magistral preparation --- compounding pharmacy --- phage therapy --- regulatory framework --- personalized medicine --- bacteriophage --- phage --- horizontal gene transfer --- co-evolution --- phage therapy --- industrial phage application --- antimicrobial resistance (AMR) --- Germany --- pH stability --- phage-host interactions --- genomics --- antibiotic-resistance --- phage preparation --- lysins --- biofilms --- typhoid fever --- Salmonella Typhi --- extended-spectrum beta lactamases (ESBL) --- Democratic Republic of the Congo --- bacteriophages --- MALDI-MS --- Staphylococcus --- bacteriophages --- phage therapy --- Kayvirus --- Viral proteins --- bacteriophage --- therapy --- phage therapy --- bacterial disease --- infection --- target selection --- Bacteriophage --- phage therapy --- resistance --- adaptation --- prophage --- production --- regulation --- phage therapy --- viral genomes --- best practices --- IND --- high-throughput sequencing --- bacteriophages --- phages --- food safety --- foodborne illness --- phage therapy --- history of science --- science communication --- bacteriophage --- phage therapy --- sustainable agriculture --- zoonosis --- antibiotic resistance --- phage therapy --- experimental therapy --- phage cocktails --- anti-phage antibodies --- prophage --- immunomodulation --- phage therapy --- evolution --- bacterial resistance --- virulence --- Listeria ivanovii --- bacteriophages --- alginate --- production --- disinfection --- phagodisinfection --- virus–host interactions --- bacteriophage efficacy --- gastrointestinal tract --- phage therapy --- bacteriophage --- phage therapy --- antimicrobial resistance --- antibiotic --- global health --- developing countries --- infectious disease --- bacteriophage --- phage --- phage therapy --- phage-resistance --- phage therapy --- bacterial infection --- capsule depolymerase --- antibiotic --- animal model --- bacterial resistance --- bacteriophage --- immunology --- innate immunity --- adaptive immunity --- human host --- phage-human host interaction --- bacterial infection --- antibiotic resistance --- bacteriophage --- antibiotic therapy --- phage therapy --- cases report --- abortive infection --- prophage --- adsorption --- Enterococcus --- rhamnopolysaccharide --- bacteriophage --- phage therapy --- Staphylococcus aureus --- biofilm --- antimicrobial --- frequency of resistance --- phage sensitivity --- resistance management --- nontraditional antibacterial --- bacteriophages --- phage therapy --- antibiotic resistance --- Pseudomonas aeruginosa --- Escherichia coli --- Staphylococcus aureus --- Brussels --- Belgium --- phage biocontrol --- patent landscape --- crop production --- bacteriophage --- phage therapy --- multidrug-resistant bacteria --- antimicrobial resistance --- bacteriophage therapy --- compassionate use --- antibiotic resistance --- phage therapy --- PTMP --- ATMP --- regulatory framework --- pharmaceutical paradigm shift --- clinical trial --- magistral formula --- personalized medicine --- phage therapy --- E. faecalis --- OrthoMCL --- antimicrobial resistance --- capsule --- Galleria mellonella --- Klebsiella pneumoniae --- phage therapy --- n/a --- antimicrobial resistance --- bacteriophage --- personalised medicines --- phage therapy --- pharmaceutical legislation --- regulatory framework

Listing 1 - 5 of 5
Sort by
Narrow your search